Dan Bloomfield

567 total citations
11 papers, 381 citations indexed

About

Dan Bloomfield is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and General Health Professions. According to data from OpenAlex, Dan Bloomfield has authored 11 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Genetics and 3 papers in General Health Professions. Recurrent topics in Dan Bloomfield's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Dan Bloomfield is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Dan Bloomfield collaborates with scholars based in United Kingdom, United States and Canada. Dan Bloomfield's co-authors include Richard Munton, Kevin Collins, Debra Freedholm, Jules Pretty, Carly Wood, Jo Barton, Mike Rogerson, B. Alexander Yi, Norman E. Lepor and Mark Lovern and has published in prestigious journals such as The Lancet, Circulation and Blood.

In The Last Decade

Dan Bloomfield

10 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Bloomfield United Kingdom	7	90	63	62	57	55	11	381
Steven Ramondt Netherlands	12	106 1.2×	3 0.0×	85 1.4×	49 0.9×	22 0.4×	21	418
Peter Lee Australia	12	8 0.1×	34 0.5×	83 1.3×	80 1.4×	39 0.7×	41	435
David L. A. Gordon Canada	14	62 0.7×	56 0.9×	140 2.3×	28 0.5×		54	657
Mary Evans United States	10	100 1.1×	24 0.4×	45 0.7×	43 0.8×	4 0.1×	18	308
Emily Lewis United States	10	12 0.1×	35 0.6×	94 1.5×	215 3.8×	3 0.1×	29	657
Sandy Bond New Zealand	13	23 0.3×		72 1.2×	11 0.2×	36 0.7×	35	460
Michael Darden United States	13	15 0.2×	13 0.2×	71 1.1×	97 1.7×	8 0.1×	46	541
Hung‐Ming Tu Taiwan	10	72 0.8×	1 0.0×	56 0.9×	33 0.6×	2 0.0×	20	427
Mick Carpenter United Kingdom	11	47 0.5×	1 0.0×	55 0.9×	78 1.4×	11 0.2×	29	456
Joop de Beer Netherlands	17	112 1.2×	10 0.2×	254 4.1×	342 6.0×	2 0.0×	53	920

Countries citing papers authored by Dan Bloomfield

Since Specialization

Citations

This map shows the geographic impact of Dan Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Bloomfield more than expected).

Fields of papers citing papers by Dan Bloomfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Bloomfield. The network helps show where Dan Bloomfield may publish in the future.

Co-authorship network of co-authors of Dan Bloomfield

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Bloomfield. A scholar is included among the top collaborators of Dan Bloomfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Bloomfield. Dan Bloomfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Patel, Siddharth M., Robert P. Giugliano, David A. Morrow, et al.. (2025). Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial. Circulation. 152(5). 290–296. 1 indexed citations

Patel, Siddharth M., Robert P. Giugliano, D. John Morrow, et al.. (2024). Abstract 4143980: Bleeding with the FXI Inhibitor Abelacimab compared with Rivaroxaban in Patients on Antiplatelet therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial. Circulation. 150(Suppl_1).

Gue, Ying X., Dan Bloomfield, Debra Freedholm, & Gregory Y.H. Lip. (2024). Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation. Journal of Clinical Medicine. 13(8). 2277–2277. 4 indexed citations

Wang, Tzu‐Fei, Alok A. Khorana, Giancarlo Agnelli, et al.. (2023). Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. The Oncologist. 28(7). 555–564. 17 indexed citations

Wallisch, Michael, Yasser Khder, Monica T. Hinds, et al.. (2021). Abelacimab Reduces Thrombus Propagation in a Baboon Model of Vascular Graft Thrombosis. Blood. 138(Supplement 1). 1027–1027. 1 indexed citations

Yi, B. Alexander, Debra Freedholm, Xiaohui Wang, et al.. (2021). Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. Journal of Thrombosis and Haemostasis. 20(2). 307–315. 72 indexed citations

Rogerson, Mike, et al.. (2020). Regular Doses of Nature: The Efficacy of Green Exercise Interventions for Mental Wellbeing. International Journal of Environmental Research and Public Health. 17(5). 1526–1526. 50 indexed citations

Bloomfield, Dan. (2017). What makes nature-based interventions for mental health successful?. BJPsych International. 14(4). 82–85. 51 indexed citations

Lovell, Rebecca, Kerryn Husk, Alison Bethel, et al.. (2017). A realist review and collaborative development of what works in the social prescribing process. The Lancet. 390. S62–S62. 11 indexed citations

10.

Husk, Kerryn, Rebecca Lovell, Alison Bethel, et al.. (2016). What approaches to social prescribing work, for whom, and in what circumstances? A protocol for a realist review. Systematic Reviews. 5(1). 93–93. 43 indexed citations

11.

Bloomfield, Dan, et al.. (2001). Deliberation and Inclusion: Vehicles for Increasing Trust in UK Public Governance?. Environment and Planning C Government and Policy. 19(4). 501–513. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact